The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Partially Folded Intermediates as Critical Precursors of Light Chain Amyloid Fibrils and Amorphous Aggregates
Abstract
Light chain, or AL, amyloidosis is a pathological condition arising from systemic extracellular deposition of monoclonal immunoglobulin light chain variable domains in the form of insoluble amyloid fibrils, especially in the kidneys. Substantial evidence suggests that amyloid fibril formation from native proteins occurs via a conformational change leading to a partially folded intermediate conformation, whose subsequent association is a key step in fibrillation. In the present investigation, we have examined the properties of a recombinant amyloidogenic light chain variable domain, SMA, to determine whether partially folded intermediates can be detected and correlated with aggregation. The results from spectroscopic and hydrodynamic measurements, including far- and near-UV circular dichroism, FTIR, NMR, and intrinsic tryptophan fluorescence and small-angle X-ray scattering, reveal the build-up of two partially folded intermediate conformational states as the pH is decreased (low pH destabilized the protein and accelerated the kinetics of aggregation). A relatively nativelike intermediate, I(N), was observed between pH 4 and 6, with little loss of secondary structure, but with significant tertiary structure changes and enhanced ANS binding, indicating exposed hydrophobic surfaces. At pH below 3, we observed a relatively unfolded, but compact, intermediate, I(U), which was characterized by decreased tertiary and secondary structure. The I(U) intermediate readily forms amyloid fibrils, whereas I(N) preferentially leads to amorphous aggregates. Except at pH 2, where negligible amorphous aggregate is formed, the amorphous aggregates formed significantly more rapidly than the fibrils. This is the first indication that different partially folded intermediates may be responsible for different aggregation pathways (amorphous and fibrillar). The data support the hypothesis that amyloid fibril formation involves the ordered self-assembly of partially folded species that are critical soluble precursors of fibrils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Tetrameric Protein Transthyretin Dissociates to a Non-native Monomer in Solution
Quintas, A., Saraiva, M. J. M., & Brito, R. M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32943 · Cited by 186
Encyclopedia of molecular biology
(1999) · Choice Reviews Online · doi:10.5860/choice.37-1280 · Cited by 177
Oberg, K. A., & Fink, A. L. (1998) · Analytical Biochemistry · doi:10.1006/abio.1997.2486 · Cited by 139
Self-citation
Cited by
Molecular Mechanisms of Amyloidosis
Merlini, G., & Bellotti, V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023144 · Cited by 1,920
Intrinsically Disordered Proteins in Human Diseases: Introducing the D2Concept
Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125924 · Cited by 1,410
Chi, E. Y., Krishnan, S., Randolph, T. W., & Carpenter, J. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1025771421906 · Cited by 1,379
Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096
Self-citationConformational constraints for amyloid fibrillation: the importance of being unfolded
Uversky, V. N., & Fink, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.12.008 · Cited by 1,015
Self-citationProtein aggregation and its inhibition in biopharmaceutics
Wang, W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.014 · Cited by 983
Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology
Wei, G., Su, Z., Reynolds, N. P., Arosio, P., Hamley, I. W., Gazit, E., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00542j · Cited by 904
Dependence of α-Synuclein Aggregate Morphology on Solution Conditions
Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T. M., & Subramaniam, V. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00775-1 · Cited by 565
ThT 101: a primer on the use of thioflavin T to investigate amyloid formation
Gade Malmos, K., Blancas-Mejia, L. M., Weber, B., Buchner, J., Ramirez-Alvarado, M., Naiki, H., & Otzen, D. (2017) · Amyloid · doi:10.1080/13506129.2017.1304905 · Cited by 445
Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides
Nguyen, H. D., & Hall, C. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407273101 · Cited by 368
Non‐native protein aggregation kinetics
Roberts, C. J. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21627 · Cited by 329
Yoshimura, Y., Lin, Y., Yagi, H., Lee, Y.-H., Kitayama, H., Sakurai, K., So, M., Ogi, H., Naiki, H., & Goto, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208228109 · Cited by 326
Uversky, V. N. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3096-6 · Cited by 314
Khurana, R., Ionescu-Zanetti, C., Pope, M., Li, J., Nielson, L., Ramírez-Alvarado, M., Regan, L., Fink, A. L., & Carter, S. A. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74550-0 · Cited by 309
Self-citationAmyloid formation under physiological conditions proceeds via a native-like folding intermediate
Jahn, T. R., Parker, M. J., Homans, S. W., & Radford, S. E. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1058 · Cited by 305
Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins
Munishkina, L. A., & Fink, A. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.015 · Cited by 294
Self-citationDistinct β-sheet structure in protein aggregates determined by ATR-FTIR spectroscopy
Shivu, B., Seshadri, S., Li, J., Oberg, K. A., Uversky, V. N., & Fink, A. L. (2013) · Biochemistry · doi:10.1021/bi400625v · Cited by 289
Self-citationTherapeutic strategies for human amyloid diseases
Sacchettini, J. C., & Kelly, J. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd769 · Cited by 261
Stathopulos, P. B., Rumfeldt, J. A. O., Scholz, G. A., Irani, R. A., Frey, H. E., Hallewell, R. A., Lepock, J. R., & Meiering, E. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1237797100 · Cited by 258
Surface-catalyzed Amyloid Fibril Formation
Zhu, M., Souillac, P. O., Ionescu-Zanetti, C., Carter, S. A., & Fink, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207225200 · Cited by 256
Self-citationStructural properties of monoclonal antibody aggregates induced by freeze–thawing and thermal stress
Hawe, A., Kasper, J. C., Friess, W., & Jiskoot, W. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.001 · Cited by 255
Andrews, J. M., & Roberts, C. J. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp070212j · Cited by 250
Metadata
- Authors
- Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., & Fink, A. L.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2001-03-01
- Volume
- 40
- Issue
- 12
- Pages
- 3525-3535
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2066072539
- Cited by
- 325
- References
- 3
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.